Monday, September 16, 2019
Home Featured


Adam Hergenreder, an 18-year-old student from Gurnee, Illinois, was hospitalized for six days with severe lung disease due to vaping. His doctors said that he had lungs that closely resembled the lungs of a 70-year-old. He required IV injections and breathing devices. The CDC has been urging people to stop vaping.
In an attempt to help Aussies fall asleep, IKEA has launched a live-streaming Slow TV Channel that creates a better sleep environment. The channel mixes the soothing sound of waves crashing the stern of the ship with the narration of nautical journey by their Sleep Podcast hosts – Kent and Sara Erikson.
The Trump Administration is considering to ban all non-tobacco flavoring e-cigarettes, as announced by President Trump in the Oval Office conference on Wednesday. The move aims to prevent children from vaping after public health officials said that they have been reporting more than 450 cases of a respiratory illnesses and six deaths associated with vaping.
Erectile Dysfunction (ED), or sexual impotence, can affect overall productivity at work and health-related quality of work, according to a new study published in the International Journal of Clinical Practice. ED is the inability of a man to achieve or sustain an erection hard enough for performing sexual intercourse.
According to a new study from Northwestern Medicine, more than 1.5 million Americans, including children and adults, have a sesame allergy. US law does not require labeling products with sesame, increasing the risk of accidental ingestion. The FDA is considering whether to make product labeling of sesame mandatory.
Louisiana state agriculture department has tested and approved the use of medical marijuana for patients. Products containing therapeutic cannabis are expected to reach selected dispensaries next week. The pharmacy board has selected nine pharmacies across the state, but it is unclear how many of them will immediately start dispensing medical marijuana.
Scientists from the University of Texas at Dallas have developed a new technology for diagnosing and managing multiple sclerosis (MS).